{{Rsnum
|rsid=1502050
|Gene=DNAH5
|Chromosome=5
|position=13779634
|Orientation=minus
|GMAF=0.2782
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=DNAH5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 53.1 | 38.9 | 8.0
| HCB | 85.4 | 14.6 | 0.0
| JPT | 80.5 | 17.7 | 1.8
| YRI | 31.3 | 49.7 | 19.0
| ASW | 43.9 | 42.1 | 14.0
| CHB | 85.4 | 14.6 | 0.0
| CHD | 77.1 | 22.9 | 0.0
| GIH | 25.7 | 48.5 | 25.7
| LWK | 39.1 | 51.8 | 9.1
| MEX | 50.0 | 34.5 | 15.5
| MKK | 30.1 | 48.1 | 21.8
| TSI | 57.8 | 40.2 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=17903303
|Trait=Other subclinical atherosclerosis traits
|Title=Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study
|RiskAllele=
|Pval=0.0000090000000000000002
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1502050
|overall_frequency_n=43
|overall_frequency_d=128
|overall_frequency=0.335938
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=36
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}